<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6734284/results/search/drugs/results.xml">
  <result pre="For patients who do not respond to common prophylactic drugs," exact="ketamine" post="infusion, onabotulinum toxin type A, intravenous (IV) lidocaine, IV"/>
  <result pre="ketamine infusion, onabotulinum toxin type A, intravenous (IV) lidocaine, IV" exact="methylprednisolone" post="and nerve blockade are possible treatment options, but even"/>
  <result pre="observed treatment response to a course of 5-days high dose" exact="methylprednisolone" post="in 9 post-infectious NDPH patients. Six of them also"/>
  <result pre="with high TNF-α levels in the CSF were given 100 mg" exact="doxycycline" post="twice daily for 3 months. Three patients reported that their"/>
  <result pre="severity of daily headaches. Rozen, has described some effects for" exact="montelukast" post="(10 mg twice daily) when added to doxycycline or minocycline"/>
  <result pre="some effects for montelukast (10 mg twice daily) when added to" exact="doxycycline" post="or minocycline to treat NDPH. However, there is no"/>
  <result pre="for montelukast (10 mg twice daily) when added to doxycycline or" exact="minocycline" post="to treat NDPH. However, there is no evidence in"/>
  <result pre="there is no evidence in the literature to support using" exact="montelukast" post="in the treatment of NDPH [ 6]. Topiramate and"/>
  <result pre="montelukast in the treatment of NDPH [ 6]. Topiramate and" exact="gabapentine" post="Rozen presented 5 NDPH patients in an abstract with"/>
  <result pre="NDPH patients in an abstract with favorable response to either" exact="gabapentin" post="or topiramate but again no good scientific evidence supports"/>
  <result pre="in an abstract with favorable response to either gabapentin or" exact="topiramate" post="but again no good scientific evidence supports using these"/>
  <result pre="et al. performed nerve blocks in painful areas with 0.5%" exact="bupivacaine" post="in 23 NDPH patients. It provided 60% acute response,"/>
  <result pre="with NDPH who received greater occipital nerve block using 1%" exact="lidocaine" post="and methylprednisolone [ 29]. Onabotulinum toxin type a (BTX)"/>
  <result pre="who received greater occipital nerve block using 1% lidocaine and" exact="methylprednisolone" post="[ 29]. Onabotulinum toxin type a (BTX) In a"/>
  <result pre="were treated with BTX injection every 3 month [ 32]. Intravenous" exact="lidocaine" post="Marmura et al. in a retrospective study, studied 68"/>
  <result pre="They suggested that patients with NDPH may benefit from IV" exact="lidocaine" post="treatment [ 33]. Akbar reported a 16-year-old boy diagnosed"/>
  <result pre="to several aggressive inpatient therapies. He was treated with IV" exact="lidocaine" post="infusion and reported that the headache fully resolved for"/>
  <result pre="severity and frequency decreased for almost 3 months [ 34]. Intravenous" exact="dihydroergotamine" post="(IV DHE) Nagy et al. studied the effect of"/>
  <result pre="those with non-migranous characteristics is less encouraging [ 35]. Intravenous" exact="ketamine" post="In a retrospective study, Pomeroy et al. treated 14"/>
  <result pre="who had previously failed aggressive treatments with a sub-anesthetic dose" exact="ketamine" post="infusion. Acute response was seen in 8 (57.1%) NDPH"/>
  <result pre="of it. As it is well tolerated, a trial of" exact="ketamine" post="might be considered reasonable in refractory NDPH cases ["/>
  <result pre="IV methylprednisolone, IV sodium valproate, anti-depressant (amitriptyline or dothiepin) and" exact="naproxene" post="for at least 3–6 months. After a median follow-up of"/>
  <result pre="month) in 30% of NDPH patients [ 16]. In summary," exact="ketamine" post="infusion, onabotulinum toxin type A, intravenous (IV) lidocaine, IV"/>
  <result pre="ketamine infusion, onabotulinum toxin type A, intravenous (IV) lidocaine, IV" exact="methylprednisolone" post="and nerve blockade are possible treatment options for patients"/>
  <result pre="ND Post-infectious new daily persistent headache may respond to intravenous" exact="methylprednisolone" post="J Headache Pain 2010 11 1 59 66 10.1007/s10194-009-0171-x"/>
  <result pre="A Response of refractory new daily persistent headache to intravenous" exact="lidocaine" post="treatment in a pediatric patient J Pain Relief 2017"/>
  <result pre="35. Nagy AJ Gandhi S Bhola R Goadsby PJ Intravenous" exact="dihydroergotamine" post="for inpatient management of refractory primary headaches Neurology 2011"/>
 </snippets>
</snippetsTree>
